Bruno Gagnon
Corporate Officer/Principal at OPTHEA LIMITED
Profile
Bruno Gagnon is a professional with experience in various firms.
He is currently working as Senior Vice President-Global Clinical Operations at Opthea Ltd.
He has previously worked as Vice President-Clinical Operations at BioMarin Pharmaceutical, Inc. and as Senior Vice President-Development Operations at Eidos Therapeutics, Inc. Mr. Gagnon has completed his graduate degree from the University of Montréal and his undergraduate degree from Université Laval.
Bruno Gagnon active positions
| Companies | Position | Start |
|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 30/06/2022 |
Former positions of Bruno Gagnon
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Operating Officer | - |
| EIDOS THERAPEUTICS, INC. | Chief Operating Officer | - |
Training of Bruno Gagnon
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private companies | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Bruno Gagnon
